Wockhardt likely to sell India business to cut debt, focus on UK: Analysts
Company left with low-margin brands in India after selling profitable ones
Wockhardt
Manufacturing · India · 2,386 Employees
View Company Info for Free
About
Headquarters
Wockhardt Towersbandra Kurla Complexbandra East...Phone Number
+91 2226534444Website
www.wockhardt.comRevenue
$334.6 MillionStock Symbol
532300Industry
Most Recent Scoops
Sep 1 2024
Left Company
Aug 1 2022
Left Company
Wockhardt has announced that Ashish Patil, Director, Information Technology, has left the organization to join Zurich North America as Assistant VP & SAP Portfolio Director.
Who is Wockhardt
Wockhardt Ltd. founded in 1999, is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. The Company's businesses inclu de the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines.Read more
Wockhardt Org Chart
Is Wockhardt your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Wockhardt, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Wockhardt had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Wockhardt
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Wockhardt has new funding data
Earning: See what the market has to say on Wockhardt recently announced quarterly report
Check out if Wockhardt is spiking on competitors!
Product Launch: Get notified when Wockhardt launches new products
Website visits: Recent activity has been detected on your website
Check if Wockhardt has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Wockhardt Employee Growth Rate
View Wockhardt’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Wockhardt Tech Stack
A closer look at the technologies used by Wockhardt
See more technologies
Most Recent Scoops
Sep 1 2024
Left Company
Executive Moves, Left Company
Nov 10 2022
Left Company
Executive Move
Aug 1 2022
Left Company
Wockhardt has announced that Ashish Patil, Director, Information Technology, has left the organization to join Zurich North America as Assistant VP & SAP Portfolio Director.
Jul 7 2022
Left Company
Executive Move
Apr 4 2022
New Hire
Executive Move
Wockhardt News & Media
Wockhardt ties up with various partners to roll out products in US market
Drug firm Wockhardt on Saturday said it has tied up with various partners to roll out products in the US market with its Illinois-based manufacturing plant all set to relieve all workers in a phased manner as part of business restructuring in the US market. The Mumbai-based company said it has engaged multiple US Food and Drug Administration (USFDA) approved manufacturing partners in the US market, after thorough due diligence and inspection of their facilities,Wockhardt reports Q1 net loss at Rs 75 cr as revenue from UK, US declines
Consolidated revenue from operations were at Rs 595 crore during the period under review, down from Rs 860 crore last year.Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US
Glenmark said its current portfolio consists of 175 products authorised for distribution in the US market and 48 ANDAs pending approval with the USFDADeepak Madnani steps up as new Chief Financial Officer of Wockhardt - IndiaInfoline
Deepak will assume the position of Pramod Gupta who has extended his resignation to the company citing health issues.
Read more news
Frequently Asked Questions Regarding Wockhardt
Wockhardt Ltd. founded in 1999, is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. The Company's businesses include the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines.... Read More
